Ludipress

Ludipress® stands as an excipient formulated from lactose monohydrate specifically designed for direct tabletting. It integrates the three essential functionalities of a filler, binder, and disintegrant within a convenient, pre-prepared excipient tailored for tablet production via direct compression technology. This white, odorless, and tasteless granulated powder comprises lactose monohydrate, Povidone K30 (Kollidon® 30), and Crospovidone (Kollidon® CL). It is versatile and suitable for use in capsules and tablets. Ludipress® adheres to the quality standards outlined by the Japan Pharmacopeia (JP), United States Pharmacopeia (USP), and European Pharmacopeia (Ph. Eur.), ensuring compliance and reliability in pharmaceutical formulations.

Ludipress® LCE presents a granulated excipient formulation composed of lactose monohydrate and Povidone K30 (Kollidon® 30). This product comprises a white to slightly yellowish, free-flowing powder specifically crafted for direct compression applications. It boasts an odorless nature and offers a neutral taste profile. Developed with specific functionalities in mind, Ludipress® LCE finds utility in chewable tablets and lozenges, serves in effervescent tablet production, and operates as a bulking agent in hard gelatin capsules. Its roles encompass acting as a binder and bulking agent. This versatile excipient is suited for various dosage forms, including capsules, lozenges, and tablets.